Ann: Immuron Plans IMM-124E Trial to Prevent Travelers Diarrhea, page-3

A necessary step to take though. Good planning is always better than having to clean up the mess afterwards...in the case of Travellers diarhoea we all know what it means!

https://www.fda.gov/drugs/cder-smal...ed-questions-pre-investigational-new-drug-ind

Can pre-IND meetings reduce time to market? Yes, time can be reduced by the following:

• Identifying and avoiding unnecessary studies
• Ensuring that necessary studies are designed to provide useful information
• Gaining FDA support for a proposed strategy
• Potentially minimizing potential for clinical hold
• Providing opportunity for creative exchange of ideas
• Obtaining regulatory insight
• Minimizing costs
• Clearly defining endpoints and goals of the development program
• Allowing early interactions/negotiations with FDA